HIV Testing

Calypte Biomedical highlights its rapid HIV urine test at conference

Published in AIDS Weekly, November 4th, 2002

Calypte Biomedical Corporation (CALY), the developer and marketer of the only two U.S. Food and Drug Administration (FDA) approved HIV-1 antibody tests for use with urine samples, shared information about the benefits and performance of its urine HIV-1 tests at the United States Conference on AIDS (USCA) held in Anaheim, California.

"At the USCA, Calypte showcased the results of the feasibility testing for the Rapid HIV Urine Test, and we experienced a similar positive reception as at the World Conference on AIDS in Barcelona," stated Nancy Katz, of Calypte Biomedical. "Several community organizations expressed their desire to participate in future clinical studies...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-11-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry